bibliographicCitation |
Tikiz C, Utük O, Bayturan O, Bayindir P, Ekmekçi C, Tikiz H. Selective COX-2 inhibition with different doses of rofecoxib does not impair endothelial function in patients with coronary artery disease. Acta Med Okayama. 2005 Feb;59(1):11–7. doi: 10.18926/amo/31984. PMID: 15902994. |